CEO interview with Edison Group
CEO Cheryl Maley spoke with Arron Aatkar, Healthcare Analyst at the Edison Group, about Starpharma’s dendrimer technology, the company’s partnerships, and its Star Navigator program. They also discuss Starpharma’s internal oncology programs, and upcoming key milestones and catalysts for investors to watch out for.
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Starpharma. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Starpharma a question about this update.